Roivant Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	20,712	7,200	8,494	5,597	3,419	502
Market Cap Growth	178.04%	-15.23%	51.75%	63.72%	580.90%	-
Enterprise Value	16,291	2,500	2,824	5,021	1,886	-
Last Close Price	28.94	10.09	10.54	7.38	4.94	9.78
PE Ratio	-	-	1.95	-	-	-
PS Ratio	1556.15	247.81	259.64	177.52	61.84	21.10
PB Ratio	4.81	1.39	1.32	3.48	1.66	0.24
P/TBV Ratio	4.85	1.54	1.42	5.53	2.06	0.28
EV/Sales Ratio	1223.99	86.05	86.33	159.25	34.11	-
Debt / Equity Ratio	0.02	0.02	0.01	0.30	0.14	0.12
Net Debt / Equity Ratio	-0.89	-0.92	-1.00	-0.74	-0.86	-0.88
Net Debt / EBITDA Ratio	3.50	4.46	8.50	1.51	2.13	-
Net Debt / FCF Ratio	5.77	5.67	8.40	1.40	2.56	3.24
Asset Turnover	0.00	0.01	0.01	0.01	0.02	0.01
Quick Ratio	29.81	32.71	24.35	6.29	11.21	9.39
Current Ratio	30.66	33.47	25.24	6.60	11.64	9.99
Return on Equity (ROE)	-19.14%	-12.54%	112.87%	-48.46%	-44.82%	-43.17%
Return on Assets (ROA)	-14.47%	-10.73%	-10.14%	-20.33%	-20.26%	-11.71%
Return on Invested Capital (ROIC)	-238.00%	-532.64%	-369.64%	-232.11%	-312.50%	-265.00%
Return on Capital Employed (ROCE)	-25.10%	-20.60%	-11.20%	-38.20%	-34.90%	-20.00%
Earnings Yield	-3.91%	-2.39%	51.20%	-18.03%	-24.72%	-161.17%
FCF Yield	-3.70%	-11.72%	-9.03%	-15.29%	-20.33%	-111.12%
Buyback Yield / Dilution	7.70%	12.71%	-16.59%	-6.43%	-6.30%	-187.64%

Updated Feb 6, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q